Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story Anthony Mthembu | Photo Supplied
Prof Tameshnie Deane
Prof Tameshnie Deane, Vice-Dean: Research, Postgraduate Studies and Internationalisation in the Faculty of Law at the University of the Free State (UFS).

The Faculty of Law at the University of the Free State (UFS) has appointed Prof Tameshnie Deane as Vice-Dean: Research, Postgraduate Studies and Internationalisation. Prof Deane officially assumed this role on 1 July 2024, following over two decades as a Professor and Head of the Criminal Law Unit at the University of South Africa (UNISA).

Prof Deane, who has approached this new position with great enthusiasm, describes it as a significant opportunity. ‘’This role allows me to influence the future of academic research and postgraduate education at UFS,’’ she said.

Support for postgraduate students

Prof Deane elaborated on her vision, saying, “My aim is to develop and implement strategies that elevate the quality and impact of research, foster innovation, and support postgraduate students in achieving their academic and professional goals.”

Among her top priorities is strengthening support for postgraduate students at the UFS. “I plan to introduce comprehensive mentorship programmes where experienced faculty members guide students through their academic and research journeys. We will offer training in key skills such as legal writing, research methodologies, and public speaking, while also prioritising initiatives to support their mental and emotional well-being,’’ she explained.

Prof Deane emphasised that creating a dynamic and supportive environment will contribute to academic excellence and personal growth for postgraduate students at the UFS.

Enhancing internationalisation and strategic collaborations

Prof Deane is also committed to advancing the internationalisation of the Faculty of Law.  “We aim to provide opportunities for international collaboration and exchange, which will broaden the scope and impact of our research and postgraduate programmes,’’ she said.

Improving research quality and output remains a core objective, with Prof Deane identifying this as central to her new role.

One of the initiatives Prof Deane is eager to lead is the development of strategic partnerships with industry and academic institutions. “Collaborations like these will provide invaluable resources for research projects,” she noted.

To foster these partnerships, Prof Deane plans to leverage technology to strengthen communication and collaboration, support relationship-building events, and promote interdisciplinary projects that encourage diverse perspectives and innovative solutions. 

News Archive

Meet Dr Olihile Sebolai, Prestige Scholar
2013-07-15

 

Dr Olihile Sebolai
Photo: Sonia Small
15 July 2013


Dr Olihile Sebolai, lecturer in the Department of Microbial, Biochemical and Food Biotechnology, was selected to the Vice-Chancellor’s Prestige Scholars Programme (PSP) in 2011. Dr Sebolai recently returned from a six month research visit to the University of Birmingham at the invitation of Professor Robin May, Lister Reader and Chair of Infectious Diseases.

This enabled Dr Sebolai to acquire and develop necessary pathobiological skills pertinent to his work on the pathogenesis of Cryptococcus neoformans. “During my time in Birmingham, I benefitted from the experiences of three senior post-doctorates and a principal investigator, who were all working in (Prof May’s) laboratory,” says Dr Sebolai.

“By way of observation, I was greatly impressed by the level of collaboration between Prof May and his network, which enables him to move out of a silo and effortlessly create a global footprint."

The next phase of Dr Sebolai’s early career development takes him as Fulbright Scholar to the University of Missouri in Kansas City, in September 2013. Here Dr Sebolai will spend time in the laboratory of Alexander Idnurm. The purpose of this visit is to study virulence mechanisms in fungi, which are a low order of eukaryotic organisms, and to identify potential drug targets.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept